Publications (43) Roberto Carlos Agis Balboa publications

2024

  1. Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors

    PLoS ONE, Vol. 19, Núm. 7 JULY

  2. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Data-Driven Phenotyping of Alzheimer’s Disease under Epigenetic Conditions Using Partial Volume Correction of PET Studies and Manifold Learning

    Biomedicines, Vol. 11, Núm. 2

  2. Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  4. MyBrain-Seq: A Pipeline for MiRNA-Seq Data Analysis in Neuropsychiatric Disorders

    Biomedicines, Vol. 11, Núm. 4

  5. Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  6. Towards a Flexible and Portable Workflow for Analyzing miRNA-Seq Neuropsychiatric Data: An Initial Replicability Assessment

    Lecture Notes in Networks and Systems

2022

  1. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

  2. On the Reproducibility of MiRNA-Seq Differential Expression Analyses in Neuropsychiatric Diseases

    Lecture Notes in Networks and Systems

2021

  1. Application of miRNA-seq in neuropsychiatry: A methodological perspective

    Computers in Biology and Medicine, Vol. 135

  2. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis

    Annals of Medicine, Vol. 53, Núm. 1, pp. 43-69

  3. Microglia: The real foe in hiv-1-associated neurocognitive disorders?

    Biomedicines, Vol. 9, Núm. 8

  4. The role of dopamine receptors in lymphocytes and their changes in schizophrenia

    Brain, Behavior, and Immunity - Health, Vol. 12

2018

  1. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship

    Schizophrenia Research, Vol. 197, pp. 19-33

  2. The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis

    Journal of Psychiatric Research, Vol. 106, pp. 43-53

  3. The role of the gut microbiota in schizophrenia: Current and future perspectives

    World Journal of Biological Psychiatry, Vol. 19, Núm. 8, pp. 571-585

2017

  1. Cambios en el perfil metabólico de pacientes psiquiátricos tras programa de ejercicio físico con enfermería

    XXI Encuentro Internacional de Investigación en Cuidados

  2. Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice

    Addiction Biology, Vol. 22, Núm. 6, pp. 1778-1789

  3. Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders

    Clinical Epigenetics, Vol. 9, Núm. 1